The CGTLive™ Endocrinology specialty topic page houses video interviews with key opinion leaders in the field of endocrinology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to cell therapies, gene therapies, and engineered and regenerative medicines developed for endocrine disorders. It also contains up-to-date clinical news coverage in the field of endocrinology gene and cell therapy.
July 16th 2025
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Mesenchymal Stem Cell Therapy an Option for Patients With Type 2 Diabetes Complications
May 17th 2022Investigators in Ukraine share data on the safety and efficacy of autologous mesenchymal stem cell administration for type 2 diabetes complications under the hypothesis that success is dependent on the administration route and quality of the autologous MSC population.